Intersect ENT to acquire Fiagon AG Medical Technologies for €60 million

Intersect ENT agreed to acquire Fiagon AG Medical Technologies, a leader in electromagnetic surgical navigation solutions, for €60 million in cash, with payments over three years.

“Fiagon represents a strategic technology acquisition for Intersect ENT that immediately expands our portfolio of ENT product offerings, complements our existing PROPEL and SINUVA sinus implants and helps extend our geographic reach.”businesswire.com

• 1 source
• businesswire.comIntersect ENT Announces Agreement to Acquire Fiagon AG Medical Technologies for €60 Million Paid Over Three YearsIntersect ENT, Inc.Sep 15, 2020

Summarized from public sources; check the original articles before acting on it.